Sort
326,823 grants matching “clinical trial”
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$1,648,746Philip Greenland · Northwestern University At Chicago · UL1 · FY2011 · RR
Continuation of the Non-Alcoholic Steatohepatitis Clinical Research Network
$1,648,657James A Tonascia · Johns Hopkins University · U01 · FY2013 · DK
Endocannabinoid Targeting for Opioid Induced Respiratory Depression
$1,648,561Tally Marie Milnes · University Of Arizona · R01 · FY2022 · DA
NCI Community Oncology Research Program Minority Underserved Community Sites
$1,648,482Carolyn Y Muller · University Of New Mexico Health Scis Ctr · UG1 · FY2017 · CA
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
$1,648,456Peter G Stock · University Of California, San Francisco · U01 · FY2016 · AI
Resetting immune homeostasis: a non-invasive approach towards HIV eradication
$1,648,370Rafick-Pierre Sekaly · Emory University · U01 · FY2021 · AI
Montana Pediatric Clinical Trials Site
$1,648,167Paul Smith · University Of Montana · UG1 · FY2016 · OD
Clinical Epidemiology &Pathogenesis of Asymptomatic HSV
$1,648,154Fred Hutchinson Cancer Research Center · P01 · FY2004 · AI
IGF::OT::IGF IMMUNOGENICITY OF NONAVALENT HPV VACCINE ADMINISTERED PRIOR TO LIVING DONOR RENAL TRANSPLANTATION IN ADULT WOMEN: A PROSPECTIVE, SINGLE-ARM, MULTI-CENTER CLINICAL TRIAL
$1,648,147Seema Khan · Northwestern University At Chicago · N01 · FY2016 · CA
Immune repertoire remodeling following B cell-targeted CAR T cells for induction of renal allograft tolerance in non-human primates
$1,648,086Ali Naji · University Of Pennsylvania · R01 · FY2025 · AI
Randomized Trial of Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
$1,648,031Michael B Rothberg · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · AG
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
$1,647,916Sarah M Fortune · Harvard Medical School · U19 · FY2023 · AI
North American AIDS Cohorts Collaboration on Research and Design
$1,647,789Richard Douglas Moore · Johns Hopkins University · U01 · FY2008 · AI
EFFECTS OF DOCOSAHEXAENOIC ACID (DHA) IN SLOWING THE PROGRESSION OF AD (DHA)
$1,647,782Joseph F Quinn · University Of California, San Diego · U01 · FY2008 · AG
Center for Lupus Research
$1,647,774Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · P50 · FY2023 · AR
INFORMATICS CORE
$1,647,744Paul S. Aisen · University Of California, San Diego · U19 · FY2019 · AG
Development
$1,647,550Peter M Howley · Dana-Farber Cancer Inst · P30 · FY2009 · CA
Deciphering CTCF code in mammalian host and viral epigenomes
$1,647,549Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Administrative Core
$1,647,468Deborah J Goff · Dana-Farber Cancer Inst · P30 · FY2024 · CA
AIDS CLINICAL TRIALS UNIT
$1,647,267University Of Pennsylvania · U01 · FY2003 · AI
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$1,647,206Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Immune Responses to AAV-Mediated FIX Gene Transfer
$1,647,124Hildegund C. J. Ertl · Wistar Institute · P01 · FY2014 · HL
DNA Sequencing and FACS Core Facilities
$1,646,795Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies
$1,646,469William W Hauswirth · University Of Florida · R24 · FY2013 · EY
INSPIRE (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients): The INSPIRE-ASP Trial for Intra-Abdominal and Skin and Soft Tissue Infections
$1,646,462Richard Platt · Harvard Pilgrim Health Care, Inc. · U01 · FY2020 · AI